Search - tctmd.com

Displaying 181 - 200 of 294

Sort: Relevancy | Date

Point/Counterpoint: Provocative Views 1 — Minimalist TAVR Gone Viral - Minimalism? Yes. Rapid Ambulation and Discharge? Yes — But GA and TEE to Optimize Outcomes in Selected Cases

Presentation TCT 2019

Minimalism? Yes. Rapid Ambulation and Discharge? Yes — But GA and TEE to Optimize Outcomes in Selected Cases

Presenter: Philippe Genereux

September 27, 2019

Presentation TCT 2019

Minimalist TAVR for Everyone: Safe, Efficient, and Cost-Effective

Presenter: David Wood

September 27, 2019

Presentation TCT 2019

TAVR for Bioprosthetic Aortic Valve Failure 2: "To Split or Not to Split" — Case Presentation and Update on the Role of BASILICA to Reduce the Risk of Coronary Obstruction During VIV Procedures

Presenter: Adam Greenbaum

September 27, 2019

Presentation TCT 2019

TAVR for Bioprosthetic Aortic Valve Failure 1: "To Crack or Not to Crack" — Case Presentation and Update on the Role of Fracturing Bioprosthetic Valves During VIV Procedures

Presenter: Adnan Chhatriwalla

September 27, 2019

Presentation TCT 2019

Extreme Aortic Valve Complex Calcification Creating High Risk for TAVR Complications (Rupture or PVR): Case Presentation and Procedural Decision-Making

Presenter: Chiu Wong

September 27, 2019

Presentation TCT 2019

TAVR and Concomitant Atrial Fibrillation: Case Presentation

Presenter: Fabian Nietlispach

September 27, 2019

Presentation TCT 2019

Argentina Presents: Is TAVR an Option for Patients With Bicuspid Aortic Stenosis and Aortic Root Dilatation?

Presenter: Anibal Damonte

September 26, 2019

News Conference News TCT 2019

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Michael O'Riordan

September 25, 2019

Presentation TCT 2019

TCT 80: Predictors of residual significant mean gradient after TAVR in bicuspid aortic valve stenosis: insights from the BEAT international collaborative registry.

Presenter: Antonio Mangieri

September 25, 2019

Presentation TCT 2019

Case Example: TAVR for Bicuspid Aortic Stenosis

Presenter: Pedro Villablanca

September 25, 2019

Presentation TCT 2019

TAVR in Bicuspid Aortic Valves

Presenter: Lars Sondergaard

September 25, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

Presentation TVT 2019

Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease?

Presenter: Vinod Thourani

June 13, 2019

Presentation TVT 2019

Better for Bicuspids and Dry Leaflet Technology

Presenter: Horst Sievert

June 13, 2019

Presentation TVT 2019

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Calcified Bicuspid Disease) – A Case-Based Discussion

Presenter: Christopher Meduri

June 13, 2019

Presentation TVT 2019

Treating Bicuspid Valves With Current Transcatheter Valve Platforms

Presenter: Didier Tchetche

June 13, 2019

Presentation TVT 2019

Treating AR With Current Transcatheter Valve Platforms

Presenter: David Muller

June 13, 2019

Presentation TVT 2019

The Next TAVR vs. SAVR Randomized Trial Should Be in Patients With Bicuspid Aortic Valves

Presenter: Raj Makkar

June 13, 2019

Presentation TVT 2019

Latest Clinical Data in Bicuspid Disease

Presenter: John Forrest

June 13, 2019

Advertisement

Minimalism? Yes. Rapid Ambulation and Discharge? Yes — But GA and TEE to Optimize Outcomes in Selected Cases

Minimalist TAVR for Everyone: Safe, Efficient, and Cost-Effective

TAVR for Bioprosthetic Aortic Valve Failure 2: "To Split or Not to Split" — Case Presentation and Update on the Role of BASILICA to Reduce the Risk of Coronary Obstruction During VIV Procedures

TAVR for Bioprosthetic Aortic Valve Failure 1: "To Crack or Not to Crack" — Case Presentation and Update on the Role of Fracturing Bioprosthetic Valves During VIV Procedures

Extreme Aortic Valve Complex Calcification Creating High Risk for TAVR Complications (Rupture or PVR): Case Presentation and Procedural Decision-Making

TAVR and Concomitant Atrial Fibrillation: Case Presentation

Argentina Presents: Is TAVR an Option for Patients With Bicuspid Aortic Stenosis and Aortic Root Dilatation?

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

TCT 80: Predictors of residual significant mean gradient after TAVR in bicuspid aortic valve stenosis: insights from the BEAT international collaborative registry.

Case Example: TAVR for Bicuspid Aortic Stenosis

TAVR in Bicuspid Aortic Valves

FDA Expands TAVR Indication to Low-Risk Patients

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Do We Need a Randomized Trial in Bicuspid Aortic Valve Disease?

Better for Bicuspids and Dry Leaflet Technology

3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Calcified Bicuspid Disease) – A Case-Based Discussion

Treating Bicuspid Valves With Current Transcatheter Valve Platforms

Treating AR With Current Transcatheter Valve Platforms

The Next TAVR vs. SAVR Randomized Trial Should Be in Patients With Bicuspid Aortic Valves

Latest Clinical Data in Bicuspid Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content